Russell Investments Group
CALC icon

Russell Investments Group’s CalciMedica CALC Stock Holding History

Russell Investments Group’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-500
Closed -$1.77K – 3806
2024
Q4 		$1.77K Buy
+500
New +$1.75K ﹤0.01% 3460

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
WIA
Wealthedge Investment Advisors New York $272M AUM 10.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

Russell Investments Group's CALC Position: Q1 2025 in Review

Russell Investments Group sold out of CalciMedica (CALC) in Q1 2025, closing a stake of 500 shares — an estimated $1.77K sold.

Russell Investments Group first reported a position in CALC in Q4 2024 and held it in 1 quarter. The position peaked at $1.77K in Q4 2024. 30 funds tracked by Wall St. Rank hold CALC as of Q1 2025.

  • Russell Investments Group reported no remaining CalciMedica position as of Q1 2025 after selling out during the quarter.
  • Russell Investments Group sold 500 CalciMedica shares in Q1 2025, an estimated $1.77K.
  • Russell Investments Group first reported a position in CalciMedica in Q4 2024 and held it in 1 quarter.
  • Russell Investments Group's CalciMedica position peaked at $1.77K in Q4 2024.
  • 30 funds tracked by Wall St. Rank held CalciMedica as of Q1 2025.

Based on Russell Investments Group's 13F filing for Q1 2025, filed 13 May 2025.